Xlife Sciences AG (CHIX:XLSZ) SpecialCharges


CHIX:XLSZ Xlife Sciences AG CHIX:XLSZ
37 GF Score
Price CHF17.90
GF Value CHF7.19
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Xlife Sciences AG SpecialCharges?

Special Charges only applies to banks.

CHIX:XLSZ
37GF Score
Xlife Sciences AG CHIX:XLSZ
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Xlife Sciences AG (CHIX:XLSZ) Overvalued in 2026?

Based on GuruFocus' analysis, Xlife Sciences AG stock appears to be overvalued. The current stock price of CHF17.90 is trading 149% above its estimated GF Value™ of CHF7.19. GuruFocus considers Xlife Sciences AG to be Significantly Overvalued.

Key valuation signals for CHIX:XLSZ:

  • SpecialCharges:
  • GF Value™: CHF7.19 vs. price of CHF17.90 (149% above fair value)
  • GF Score™: 37/100 with 10 warning signs

No single metric tells the full story. See the CHIX:XLSZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Xlife Sciences AG Business Description

Other Exchanges XLS:GermanyXLS:Switzerland
Address Talacker 35, Zurich, CHE, 8001
Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high-unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments, which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial Intelligence/Digital Medicine.
37GF Score

Get the complete analysis for CHIX:XLSZ

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF17.90
Price
CHF7.19
GF Value